참고문헌
- Buckland P R (2004). Allele-specific gene expression differences in humans. Hum Mol Genet, 13, 255-60. https://doi.org/10.1093/hmg/ddh227
- Chen X, Leung S Y, Yuen S T, et al (2003). Variation in gene expression patterns in human gastric cancers. Mol Biol Cell, 14, 3208-15. https://doi.org/10.1091/mbc.E02-12-0833
- Emdad L, Sarkar D, Su Z Z, et al (2007). Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther, 114, 155-70. https://doi.org/10.1016/j.pharmthera.2007.01.010
- Emdad L, Sarkar D, Su Z Z, et al (2006). Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res, 66, 1509-16. https://doi.org/10.1158/0008-5472.CAN-05-3029
- Jian-bo X, Hui W, Yu-long H, et al (2010). Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol, 28, 455-62.
- Keeney S, Bauer T L (2006). Epidemiology of adenocarcinoma of the esophagogastric junction. Surgical Oncology clinics of North Am, 15, 687-96. https://doi.org/10.1016/j.soc.2006.07.014
- Kikuno N, Shiina H, Urakami S, et al (2007). Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 26, 7647-55. https://doi.org/10.1038/sj.onc.1210572
- Kim D H, Mohapatra G, Bollen A, Waldman F M, Feuerstein B G (1995). Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer, 60, 812-9. https://doi.org/10.1002/ijc.2910600615
- Lee S G, Jeon H Y, Su Z Z, et al (2009). Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene, 28, 2476-84. https://doi.org/10.1038/onc.2009.93
- Lee S G, Su Z Z, Emdad L, Sarkar D, Fisher P B (2006). Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci USA, 103, 17390-5. https://doi.org/10.1073/pnas.0608386103
- Lee S G, Su Z Z, Emdad L, et al (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene, 27, 1114-21. https://doi.org/10.1038/sj.onc.1210713
- Li J, Yang L, Song L, et al (2009). Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene, 28, 3188-96. https://doi.org/10.1038/onc.2009.171
- Li J, Zhang N, Song L B, et al (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res, 14, 3319-26. https://doi.org/10.1158/1078-0432.CCR-07-4054
- Li X, Kong X, Huo Q, et al (2011). Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci, 102, 1151-7. https://doi.org/10.1111/j.1349-7006.2011.01919.x
- Liu L, Wu J, Ying Z, et al (2010). Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res, 70, 3750-9. https://doi.org/10.1158/0008-5472.CAN-09-3838
- Malekzadeh R, Derakhshan M H, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
- Mowla S J, Emadi Bayegi M, Ziaee S A, Nikpoor P (2005). Evaluating expression and potential diagnostic and prognostic values of Survivin in bladder tumors: a preliminary report. Urology J, 2, 141-7.
- Nikpour P, Mowla S J, Jafarnejad S M, Fischer U, Schulz W A (2009). Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710. Cell Proliferation, 42, 762-9. https://doi.org/10.1111/j.1365-2184.2009.00635.x
- Ooi C H, Ivanova T, Wu J, et al (2009). Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet, 5, 1000676. https://doi.org/10.1371/journal.pgen.1000676
- Poon T C, Wong N, Lai P B, et al (2006). A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. Gastroenterology, 131, 1262-70. https://doi.org/10.1053/j.gastro.2006.08.014
- Santarpia M, Magri I, Sanchez-Ronco M, et al (2011). mRNA expression levels and genetic status of genes involved in the EGFR and NF-kappaB pathways in metastatic non-small-cell lung cancer patients. J Transl Med, 9, 163. https://doi.org/10.1186/1479-5876-9-163
- Sarkar D, Emdad L, Lee S G, et al (2009). Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes. Cancer Res, 69, 8529-35. https://doi.org/10.1158/0008-5472.CAN-09-1846
- Sarkar D, Park E S, Emdad L, et al (2008). Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res, 68, 1478-84. https://doi.org/10.1158/0008-5472.CAN-07-6164
- Song H, Li C, Li R, Geng J (2010). Prognostic significance of AEG-1 expression in colorectal carcinoma. Int J Colorectal Dis, 25, 1201-9. https://doi.org/10.1007/s00384-010-1009-3
- Song L, Li W, Zhang H, et al (2009). Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. J Pathol, 219, 317-26. https://doi.org/10.1002/path.2595
- The National Cancer Registry (2008). Fourth national report on cancer incidence and mortality. Ministry of Health and Medical Education, Tehran, Iran.
- Thirkettle H J, Girling J, Warren A Y, et al (2009). LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res, 15, 3003-13. https://doi.org/10.1158/1078-0432.CCR-08-2046
- Wang Y, Klijn J G, Zhang Y, et al (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365, 671-9. https://doi.org/10.1016/S0140-6736(05)17947-1
- Yoo B K, Emdad L, Su Z Z, et al (2009). Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest, 119, 465-77. https://doi.org/10.1172/JCI36460
- Yu C, Chen K, Zheng H, et al (2009). Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis, 30, 894-901. https://doi.org/10.1093/carcin/bgp064
피인용 문헌
- EYA1 expression in gastric carcinoma and its association with clinicopathological characteristics: a pilot study vol.31, pp.5, 2014, https://doi.org/10.1007/s12032-014-0955-y
- Metadherin expression and lung relapse in patients with colorectal carcinoma vol.31, pp.6, 2014, https://doi.org/10.1007/s10585-014-9659-0
- Long noncoding RNAs in gastric cancer carcinogenesis and metastasis pp.2041-2657, 2016, https://doi.org/10.1093/bfgp/elw011
- Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients vol.34, pp.8, 2017, https://doi.org/10.1007/s12032-017-0994-2
- Progress of cancer research on astrocyte elevated gene-1/Metadherin (Review) vol.8, pp.2, 2014, https://doi.org/10.3892/ol.2014.2231
- MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6558